| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| sodium chloride 2.34 g/L + potassium acetate 1.28 g (potassium 13 mmol)/L + magnesium acetate tetrahydrate 320 mg/L + glucose 5% (50 g/L) injection, bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| normal immunoglobulin 1 g/10 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| king brown snake antivenom 18 000 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| normal immunoglobulin 5 g/50 mL injection, bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| dextran-1 3 g/20 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| normal immunoglobulin 3.2 g/20 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| normal immunoglobulin 5 g/100 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| clindamycin 300 mg/2 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| normal immunoglobulin 12 g/200 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| normal immunoglobulin 5 g/50 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| alprostadil 500 microgram / 1 mL injection, 1 mL ampoule (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| normal immunoglobulin 12 g/100 mL injection, bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| normal immunoglobulin 5 g/100 mL injection, bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| normal immunoglobulin 10 g/200 mL injection, bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| normal immunoglobulin 20 g/200 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| normal immunoglobulin 6 g/50 mL injection, bottle |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| normal immunoglobulin 1.6 g/10 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| iron (as polymaltose) 100 mg/2 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| normal immunoglobulin 2 g/20 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| heparin sodium 2000 units/L + sodium chloride 0.9% (9 g/L) injection, bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| normal immunoglobulin 3 g/50 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| normal immunoglobulin 600 mg/10 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| normal immunoglobulin 2.5 g/50 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| heparin sodium 1000 units/500 mL + sodium chloride 0.9% (4.5 g/500 mL) injection, bag |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| gadoteric acid 5.59 g/20 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| normal immunoglobulin 10 g/100 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| dalteparin sodium 12 500 anti-Xa units/0.5 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| gadoteric acid 2.79 g/10 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| normal immunoglobulin 6 g injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| exenatide 10 microgram/0.04 mL injection, unit dose |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| dalteparin sodium 5000 anti-Xa units/0.2 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| gadoteric acid 4.19 g/15 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Haemophilus influenzae type b vaccine 7.5 microgram/0.5 mL injection, vial |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| exenatide 5 microgram/0.02 mL injection, unit dose |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| insulin neutral bovine 100 units/mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| dalteparin sodium 18 000 anti-Xa units/0.72 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| gadoteric acid 1.4 g/5 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| dalteparin sodium 2500 anti-Xa units/0.2 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| gadoteric acid 2.79 g/10 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| eptacog alfa (activated) 2.4 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| dalteparin sodium 15 000 anti-Xa units/0.6 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| eptacog alfa (activated) 1.2 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| dalteparin sodium 7500 anti-Xa international units / 0.75 mL injection, 0.75 mL syringe (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| oxycodone hydrochloride 20 mg/2 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| eptacog alfa (activated) 4.8 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| dalteparin sodium 10 000 anti-Xa units/mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| ganciclovir 500 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Bordetella pertussis, acellular pertussis toxoid vaccine 20 microgram + Bordetella pertussis, filamentous haemagglutinin vaccine 20 microgram + Bordetella pertussis, fimbriae types 2 and 3 vaccine 5 microgram + Bordetella pertussis, acellular pertactin vaccine 3 microgram + diphtheria toxoid vaccine 30 units + tetanus toxoid vaccine 40 units + poliomyelitis virus type 1 (Mahoney) inactivated vaccine 40 D antigen units + poliomyelitis virus type 2 (MEF1) inactivated vaccine 8 D antigen units + poliomyelitis virus type 3 (Saukett) inactivated vaccine 32 D antigen units injection, 0.5 mL vial |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| Bordetella pertussis, acellular pertussis toxoid vaccine 2.5 microgram + Bordetella pertussis, filamentous haemagglutinin vaccine 5 microgram + Bordetella pertussis, fimbriae types 2 and 3 vaccine 5 microgram + Bordetella pertussis, acellular pertactin vaccine 3 microgram + diphtheria toxoid vaccine 2 units + tetanus toxoid vaccine 20 units + poliomyelitis virus type 1 (Mahoney) inactivated vaccine 40 D antigen units + poliomyelitis virus type 2 (MEF1) inactivated vaccine 8 D antigen units + poliomyelitis virus type 3 (Saukett) inactivated vaccine 32 D antigen units injection, 0.5 mL syringe |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| procaine hydrochloride 40 mg/2 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Bordetella pertussis, acellular pertussis toxoid vaccine 2.5 microgram + Bordetella pertussis, filamentous haemagglutinin vaccine 5 microgram + Bordetella pertussis, fimbriae types 2 and 3 vaccine 5 microgram + Bordetella pertussis, acellular pertactin vaccine 3 microgram + diphtheria toxoid vaccine 2 units + tetanus toxoid vaccine 20 units + poliomyelitis virus type 1 (Mahoney) inactivated vaccine 40 D antigen units + poliomyelitis virus type 2 (MEF1) inactivated vaccine 8 D antigen units + poliomyelitis virus type 3 (Saukett) inactivated vaccine 32 D antigen units injection, 0.5 mL vial |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| stonefish antivenom 2000 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| flupentixol decanoate 20 mg/mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| flupentixol decanoate 40 mg/2 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| denosumab 60 mg/mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| indigo carmine 20 mg/5 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| denosumab 120 mg/1.7 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| flupentixol decanoate 100 mg/mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| pemetrexed 500 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| pemetrexed 100 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| dibasic potassium phosphate 1.83 g/10 mL + monobasic potassium phosphate 540 mg/10 mL (total potassium 25 mmol/10 mL) injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| remifentanil 1 mg injection, 1 mg vial (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| remifentanil 2 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| vinblastine sulfate 10 mg/10 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| monobasic potassium phosphate 1.361 g (potassium 10 mmol)/10 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| remifentanil 5 mg injection, 5 mg vial (medicinal product unit of use) |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| dibasic potassium phosphate 1.053 g/10 mL + monobasic potassium phosphate 1.093 g/10 mL (total potassium 20 mmol/10 mL) injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| monobasic potassium phosphate 1.361 g (potassium 10 mmol)/10 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| poliomyelitis virus type 1 (Mahoney) inactivated vaccine 40 D antigen units + poliomyelitis virus type 2 (MEF1) inactivated vaccine 8 D antigen units + poliomyelitis virus type 3 (Saukett) inactivated vaccine 32 D antigen units injection, 0.5 mL syringe |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| droperidol 2.5 mg/mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| danaparoid sodium 750 anti-Xa units/0.6 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| oxycodone hydrochloride 10 mg/mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| Haemophilus influenzae type b vaccine 7.5 microgram + hepatitis B vaccine 5 microgram injection, 0.5 mL vial |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| intrathecal injection |
Is a |
True |
injection |
Inferred relationship |
Some |
|
| oxycodone hydrochloride 50 mg/mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| eculizumab 300 mg/30 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| lepirudin 50 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| incobotulinumtoxinA 50 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| pneumococcal 13 valent polysaccharide conjugate vaccine 30.8 microgram/0.5 mL injection, syringe |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| anti-D rho immunoglobulin 625 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| anti-D rho immunoglobulin 250 units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| oxaliplatin 100 mg/20 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| anti-D rho immunoglobulin 1500 units/2 mL injection, syringe |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| oxaliplatin 50 mg/10 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| oxaliplatin 100 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| phenylephrine hydrochloride 10 mg/mL (1%) injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| oxaliplatin 150 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| calcium chloride dihydrate 1.2 g/5 L + glucose 9.8 g/5 L + sodium lactate 25.5 g/5 L + magnesium chloride 760 mg/5 L + potassium chloride 370 mg/5 L + sodium chloride 27.6 g/5 L injection, bag |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| oxaliplatin 200 mg/40 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| oxaliplatin 50 mg injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| patent blue V 50 mg/2 mL injection, ampoule |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| asparaginase 10 000 Kyowa units injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| hepatitis B vaccine 40 microgram/mL injection, vial |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| hepatitis B vaccine 10 microgram/0.5 mL injection, syringe |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| dexmedetomidine 200 microgram/2 mL injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| hepatitis B vaccine 20 microgram/mL injection, vial |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| hepatitis B vaccine 10 microgram/mL injection, vial |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| ropivacaine hydrochloride monohydrate 20 mg/10 mL injection, ampoule |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| fibrinogen 1 g injection, vial |
has manufactured dose form |
True |
injection |
Inferred relationship |
Some |
|
| ropivacaine hydrochloride monohydrate 40 mg/20 mL injection, ampoule |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|
| hepatitis B vaccine 5 microgram/0.5 mL injection, vial |
has manufactured dose form |
False |
injection |
Inferred relationship |
Some |
|